ORT-247

N/A

Report date: 2025/05/28 11:27:25

Base Information

Drug NameORT-247
Drug Alias NameORT247ORT-247
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionErythropoietin-producing hepatocellular receptor A4 blockers
TargetsErythropoietin-producing hepatocellular receptor A4
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrthogonal Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrthogonal Neuroscience Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A